Objectives: The HEMVACO study evaluated the humoral response after mRNA anti-SARS-CoV-2 vaccination in an hematological cohort.
Methods: HEMVACO was a prospective, multicentric study registered in ClinicalTrials.gov, number NCT04852796.
Objective: We describe a clinico-radiological presentation of inflammatory optic neuropathy that mimicked optic neuritis.
Methods: Retrospective single-center case series and literature review of optic neuropathy without orbital pseudotumor.
Results: Five local patients fulfilled the inclusion criteria.